Opinion statement Despite the increase of breast cancer incidence with age, approximately
7 to 10% ofwomen diagnosed with breast cancer are younger than the age 40. This …

Prostate and breast cancer are the two cancers with the highest incidence in men and
women, respectively. Here, we focus on the known biology of acquired resistance to …

Although significant progress has been made in the implementation of new breast cancer
treatments over the last three decades, this neoplasm annually continues to show high …

Nanoparticles (NPs) containing the hydrophilic drug salidroside (Sal) and the hydrophobic
drug tamoxifen (Tam) were prepared using a triblock copolymer poly (lactic-co-glycolic …

Limited predictable long noncoding RNA (lncRNA) signature was reported in tamoxifen
resistance among estrogen receptor (ER)-positive breast cancer (BC) patients. The aim of …

Background Adding ovarian function suppression (OFS) after chemotherapy improves
survival in young women with moderate-and high-risk breast cancer. Assessment of ovarian …

Prostate and breast cancer are the two cancers with the highest incidence in men and
women, respectively. Here, we focus on the known biology of acquired resistance to …

Breast cancer has been identified as the most common malignant tumors among women
and the morbidity of breast cancer is still increasing rapidly. MEX3A possesses important …

Efficacy and Safety of Vinorelbine Plus Cisplatin vs. Gemcitabine Plus Cisplatin for Treatment
of Metastatic Triple-Negative Breast Cancer After Failure with Anthracyclines and Taxanes …

A 1-month formulation of the gonadotrophin-releasing hormone agonist (GnRHa) triptorelin
(Decapeptyl®) has been approved in the EU as an adjuvant treatment in combination with …